Daniel Virnich, MD, highlights the need for proactive social determinants of health screening, language-inclusive clinical trial practices, value-based treatment decisions, and policy reforms to improve equitable access to cancer care.
Daniel Virnich, MD
Advertisement
Articles by Daniel Virnich, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5